Representative before the EPO

Employment test 51 - 200 employees
Company dna august and debouzy
operating since 1995
Headquarter in Paris and 2 offices
active in Legal Services and IP Consulting

Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

We have observed 51 EP applications Edouard Kling has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after August 30, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP14766086

COMPOUNDS USEFUL AS IMMUNOMODULATORS

IPC classification:
C07D 207/08, C07D 265/30, C07D 205/08, C07C 233/03, C07D 249/08, C07D 405/12, C07C 211/03, C07D 333/32, C07D 333/20, C07C 205/02, C07D 319/18, C07D 223/06, C07D 217/02, C07D 311/14, C07D 211/60
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
The patent has been granted
EP13767179

ARYL ETHER-BASE KINASE INHIBITORS

IPC classification:
A61P 25/00, A61K 31/444, C07D 491/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
The patent has been granted
EP14815171

4,4'-BIPHENYLDIYL-BIS-(1 H-IMIDAZOLYL) DERIVATIVES AS HEPATITIS HCV INHIBITORS

IPC classification:
A61P 31/12, A61K 31/4025, C07D 405/14
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
EXAMINATION REQUESTED
EP15747721

PYRIMIDINONES AS FACTOR XIA INHIBITORS

IPC classification:
A61P 7/02, A61K 31/4162, C07D 471/18
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
The patent has been granted
EP15704881

QUINOLINE-BASED KINASE INHIBITORS

IPC classification:
A61P 25/28, A61P 25/18, A61P 25/16, A61P 25/02, A61P 25/00, A61K 31/506, A61K 31/4725, A61K 31/4709, C07D 471/04, C07D 413/04, C07D 401/04, C07D 215/18, C07D 215/12, C07D 401/14
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
EXAMINATION REQUESTED
EP14704047

ARYL LACTAM KINASE INHIBITORS

IPC classification:
A61P 25/28, A61P 25/16, A61P 25/02, C07D 471/04, A61K 31/4375
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
EXAMINATION REQUESTED
EP15705428

MACROCYCLES WITH AROMATIC P2' GROUPS AS FACTOR XIA INHIBITORS

IPC classification:
A61P 7/00, A61K 31/529, C07D 487/08, C07D 471/08
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
EXAMINATION REQUESTED
EP15705860

MACROCYCLES WITH HETROCYCLIC P2' GROUPS AS FACTOR XIA INHIBITORS

IPC classification:
A61P 7/00, A61K 31/529, C07D 487/08, C07D 471/08
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
The patent has been granted
EP15705427

MACROCYCLIC FACTOR XIA INHIBITORS CONDENSED WITH HETEROCYCLES

IPC classification:
A61P 9/10, A61K 31/439, C07D 487/08, C07D 471/18
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
The patent has been granted
EP15717342

BIARYL KINASE INHIBITORS

IPC classification:
A61P 25/28, A61K 31/495, A61K 31/435, A61K 31/351, A61K 31/505, C07D 471/04, C07D 237/08, C07D 401/04, C07D 309/18, C07D 213/74, C07D 401/14
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
EXAMINATION REQUESTED
EP15734515

HEPATITIS C VIRUS INHIBITORS

IPC classification:
C07K 5/062, C07K 5/083
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
EXAMINATION REQUESTED
EP15742478

SPIROCYCLOHEPTANES AS INHIBITORS OF ROCK

IPC classification:
A61P 9/00, A61K 31/502, C07D 519/00, C07D 513/04, C07D 471/04, C07D 417/14, C07D 417/12, C07D 237/32, C07D 403/08, C07D 413/14, C07D 403/12
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
EXAMINATION REQUESTED
EP15747706

HETEROCYCLIC KINASE INHIBITORS

IPC classification:
C07D 471/04, C07D 417/04, C07D 413/04, C07D 403/04, C07D 401/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
EXAMINATION REQUESTED
EP15756322

TIED-BACK BENZAMIDE DERIVATIVES AS POTENT ROCK INHIBITORS

IPC classification:
A61K 31/437, A61K 31/4155, C07D 413/14, C07D 405/14, C07D 401/14, C07D 403/12
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
EXAMINATION REQUESTED
EP15763756

DIAMIDE MACROCYCLES THAT ARE FXIA INHIBITORS

IPC classification:
A61P 7/02, A61K 31/395, C07D 409/12, C07D 403/06, C07D 401/12, C07D 401/06, C07D 403/12
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
Request for examination was made
EP15790314

CYCLOBUTANE CONTAINING CARBOXYLIC ACID GPR120 MODULATORS

IPC classification:
A61P 3/10, A61P 3/06, A61P 9/10, A61K 31/192, C07C 62/34, C07C 59/90, C07D 213/70, C07D 213/643, C07C 59/72
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
Request for examination was made
EP15763798

PHENYL-(AZA)CYCLOALKYL CARBOXYLIC ACID GPR120 MODULATORS

IPC classification:
A61K 31/44, A61K 31/55, A61K 31/445, A61K 31/192, A61P 3/00, C07C 62/34, C07C 59/68, C07C 59/64, C07D 213/65, C07D 211/46, C07D 211/42, C07D 211/14, C07D 207/12, C07D 205/04, C07D 223/08
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
Request for examination was made
EP15766344

CYCLOPROPANECARBOXYLIC ACID GPR120 MODULATORS

IPC classification:
A61P 3/10, A61K 31/185, A61K 31/33, C07D 277/593, C07C 62/34, C07D 307/82, C07D 207/323, C07D 231/12
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
Request for examination was made
EP14776949

MACROCYCLIC INHIBITORS OF THE PD-1/PD-L1 AND CD80 (B7-1)/PD-LI PROTEIN/PROTEIN INTERACTIONS

IPC classification:
G01N 33/574, C07K 7/08, A61K 38/10
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
Request for examination was made
EP15778153

QUINAZOLINE-BASED KINASE INHIBITORS

IPC classification:
A61P 25/00, A61P 25/16, A61P 25/28, A61K 31/517
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
Request for examination was made
EP15781564

IMMUNOMODULATORS

IPC classification:
G01N 33/68, A61K 38/12, C07K 7/56, C07K 7/52
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
Request for examination was made
EP15801052

MACROCYCLIC PEPTIDES USEFUL AS IMMUNOMODULATORS

IPC classification:
A61P 37/06, A61K 38/12, G01N 33/68, C07K 7/56, C07K 7/08
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
Request for examination was made
EP15820775

IMMUNOMODULATORS

IPC classification:
A61K 38/12, A61P 37/02, C07K 7/08
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
Request for examination was made
EP15820747

IMMUNOMODULATORS

IPC classification:
A61P 35/00, A61K 38/12, C07K 7/54
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
Request for examination was made
EP15823892

TGF RECEPTOR ANTAGONISTS

IPC classification:
A61P 35/00, A61K 31/506, A61K 31/501, A61K 31/497, A61K 31/4985, A61K 31/5377, A61K 31/496, A61K 31/444, C07D 487/04, C07D 471/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
Request for examination was made
EP16703378

CYCLIC UREAS AS INHIBITORS OF ROCK

IPC classification:
A61P 9/00, C07D 471/04, C07D 401/14, C07D 487/04, A61K 31/498, A61K 31/422, A61K 31/4178, C07D 413/10, C07D 403/10, C07D 401/10
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
Request for examination was made
EP16710344

IMMUNOMODULATORS

IPC classification:
A61P 35/00, A61K 38/12, C07K 7/54
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
Request for examination was made
EP16711084

LACTAMS AS INHIBITORS OF ROCK

IPC classification:
A61P 35/00, A61P 29/00, A61P 25/00, A61P 21/00, A61P 9/00, A61K 31/437, C07D 403/14, C07D 471/14, C07D 471/04, C07D 417/14, C07D 405/14, C07D 403/10
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
Request for examination was made
EP16713226

IMMUNOMODULATORS

IPC classification:
C07K 7/08
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
Request for examination was made
EP16725289

TRICYCLIC SULFONES AS ROR MODULATORS

IPC classification:
A61P 37/08, A61P 35/00, A61P 11/06, A61P 3/00, A61K 31/407, A61K 31/403, A61K 31/35, C07D 417/04, C07D 409/04, C07D 215/36, C07D 209/30
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
Request for examination was made
EP17189935

PYRIMIDINONES AS FACTOR XIA INHIBITORS

IPC classification:
A61P 7/02, A61K 31/4162, C07D 471/18
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
The application has been published
EP16728137

TRICYCLIC COMPOUNDS AS ANTICANCER AGENTS

IPC classification:
A61P 35/00, A61K 31/437, C07D 471/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
Request for examination was made
EP16728765

TRICYCLIC COMPOUNDS AS ANTICANCER AGENTS

IPC classification:
A61P 35/02, A61K 31/437, C07D 471/14
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
Request for examination was made
EP16729454

4-HYDROXY-3-(HETEROARYL)PYRIDINE-2-ONE APJ AGONISTS FOR USE IN THE TREATMENT OF CARDIOVASCULAR DISORDERS

IPC classification:
A61P 9/00, A61K 31/4439, C07D 417/14, C07D 413/04, C07D 401/04, C07D 413/14
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
Request for examination was made
EP16725307

5H-PYRIDO[3,2-B]INDOLE COMPOUNDS AS ANTICANCER AGENTS

IPC classification:
A61P 35/00, A61K 31/437, C07D 471/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
Request for examination was made
EP16732191

DIAMIDE MACROCYCLES AS FACTOR XIA INHIBITORS

IPC classification:
A61P 9/00, A61P 7/00, A61K 31/4155, A61K 31/4178, A61K 31/4192, A61K 31/4427, A61K 31/4439, A61K 31/513, C07D 401/04, C07D 403/12, C07D 401/14, C07D 403/14
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
Request for examination was made
EP16734538

HETEROARYL SUBSTITUTED AMINOPYRIDINE COMPOUNDS

IPC classification:
A61P 29/00, A61K 31/519, A61K 31/437, C07D 487/04, C07D 471/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
Request for examination was made
EP16734832

HETEROARYL SUBSTITUTED AMINOPYRIDINE COMPOUNDS

IPC classification:
A61P 37/00, A61K 31/519, A61K 31/5025, C07D 487/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
Request for examination was made
EP16747941

TGF BETA RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/53, A61P 35/00, C07D 487/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
Request for examination was made
EP16747714

FACTOR XIA MACROCYCLIC INHIBITORS BEARING ALKYL OR CYCLOALKYL P2' MOIETIES

IPC classification:
A61P 7/02, A61K 31/4353, C07D 491/20, C07D 471/20, C07D 471/06, C07D 471/04, C07D 403/14, C07D 403/12
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
Request for examination was made
EP16747979

TGF BETA RECEPTOR ANTAGONISTS

IPC classification:
A61P 35/00, A61K 31/5377, A61K 31/519, C07D 487/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
Request for examination was made
EP16747990

FACTOR XIA NEW MACROCYCLE BEARING A NON-AROMATIC P2' GROUP

IPC classification:
A61P 7/02, A61K 31/4985, C07D 487/04, C07D 403/14, C07D 401/14, C07D 403/12
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
Request for examination was made
EP16750350

NOVEL SUBSTITUTED GLYCINE DERIVED FXIA INHIBITORS

IPC classification:
A61P 7/02, A61K 31/4178, C07D 487/04, C07D 471/10, C07D 471/08, C07D 471/04, C07D 417/14, C07D 403/14, C07D 403/10, C07D 237/14, C07D 401/10, C07D 413/14, C07D 405/14, C07D 401/14
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
Request for examination was made
EP16750343

HETEROCYCLIC COMPOUNDS USEFUL AS MODULATORS OF TNF ALPHA

IPC classification:
A61P 29/00, A61K 31/4709, A61K 31/4706, C07D 471/04, C07D 417/12, C07D 413/12, C07D 409/12, C07D 405/12, C07D 401/04, C07D 215/42, C07D 413/14, C07D 405/14, C07D 401/14
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
Request for examination was made
EP16748045

CYCLIC COMPOUNDS USEFUL AS MODULATORS OF TNF ALPHA

IPC classification:
A61P 37/00, C07D 487/04, A61K 31/4188, A61K 31/4184, C07D 487/14
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
Request for examination was made
EP16759926

TGF BETA RECEPTOR ANTAGONISTS

IPC classification:
A61P 35/00, A61K 31/52, C07D 473/34
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
Request for examination was made
EP16763153

TGF BETA RECEPTOR ANTAGONISTS

IPC classification:
A61P 35/00, A61K 31/53, C07D 519/00, C07D 487/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
Request for examination was made
EP16781938

BIARYL KINASE INHIBITORS

IPC classification:
C07D 487/04, C07D 471/04, C07D 417/12, C07D 417/04, C07D 413/12, C07D 239/72, C07D 409/12, C07D 239/42, C07D 239/36, C07D 405/12, C07D 401/12, C07D 401/04, C07D 213/75, C07D 213/74, C07D 231/12
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
Request for examination was made
EP16785279

BIARYL KINASE INHIBITORS

IPC classification:
C07D 213/63, C07D 213/61, C07D 213/26, C07D 471/04, C07D 239/34, C07D 239/30, C07D 239/26, C07D 237/20, C07D 213/85, C07D 213/73, C07D 413/14, C07D 401/14, C07D 239/42, C07D 213/75, C07D 401/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
Request for examination was made
EP16788857

COMPOUNDS USEFUL AS IMMUNOMODULATORS

IPC classification:
A61P 37/00, A61P 35/00, A61K 31/4427, C07D 207/12, C07D 455/02, C07D 401/12, C07D 213/85, C07D 213/71, C07D 401/14, C07D 403/12
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
Request for examination was made
EP16784732

2,4-DIHYDROXY-NICOTINAMIDES AS APJ AGONISTS

IPC classification:
A61P 9/00, A61K 31/4427, C07D 498/10, C07D 491/107, C07D 471/10, C07D 417/14, C07D 417/12, C07D 413/12, C07D 401/12, C07D 401/06, C07D 213/82, C07D 413/14, C07D 405/14, C07D 401/14
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
Request for examination was made

Please Sign in to use this feature